1
|
Grima LL, Panayi MC, Härmson O, Syed ECJ, Manohar SG, Husain M, Walton ME. Correction to: Nucleus accumbens D1-receptors regulate and focus transitions to reward-seeking action. Neuropsychopharmacology 2022; 47:1734. [PMID: 35610361 PMCID: PMC9283380 DOI: 10.1038/s41386-022-01343-z] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Affiliation(s)
- Laura L Grima
- Department of Experimental Psychology, University of Oxford, Oxford, UK.
- Janelia Research Campus, Howard Hughes Medical Institute, Ashburn, VA, USA.
| | - Marios C Panayi
- Department of Experimental Psychology, University of Oxford, Oxford, UK
- National Institute on Drug Abuse, Biomedical Research Center, Baltimore, MD, USA
| | - Oliver Härmson
- Department of Experimental Psychology, University of Oxford, Oxford, UK
- Medical Research Council Brain Network Dynamics Unit, University of Oxford, Oxford, UK
| | - Emilie C J Syed
- Department of Experimental Psychology, University of Oxford, Oxford, UK
| | - Sanjay G Manohar
- Department of Experimental Psychology, University of Oxford, Oxford, UK
- Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK
| | - Masud Husain
- Department of Experimental Psychology, University of Oxford, Oxford, UK
- Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK
- Wellcome Centre for Integrative Neuroimaging, University of Oxford, Oxford, UK
| | - Mark E Walton
- Department of Experimental Psychology, University of Oxford, Oxford, UK.
- Wellcome Centre for Integrative Neuroimaging, University of Oxford, Oxford, UK.
| |
Collapse
|
2
|
Grima LL, Panayi MC, Härmson O, Syed ECJ, Manohar SG, Husain M, Walton ME. Nucleus accumbens D1-receptors regulate and focus transitions to reward-seeking action. Neuropsychopharmacology 2022; 47:1721-1731. [PMID: 35478011 PMCID: PMC9283443 DOI: 10.1038/s41386-022-01312-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/06/2021] [Revised: 02/17/2022] [Accepted: 03/10/2022] [Indexed: 11/25/2022]
Abstract
It is well established that dopamine transmission is integral in mediating the influence of reward expectations on reward-seeking actions. However, the precise causal role of dopamine transmission in moment-to-moment reward-motivated behavioral control remains contentious, particularly in contexts where it is necessary to refrain from responding to achieve a beneficial outcome. To examine this, we manipulated dopamine transmission pharmacologically as rats performed a Go/No-Go task that required them to either make or withhold action to gain either a small or large reward. D1R Stimulation potentiated cue-driven action initiation, including fast impulsive actions on No-Go trials. By contrast, D1R blockade primarily disrupted the successful completion of Go trial sequences. Surprisingly, while after global D1R blockade this was characterized by a general retardation of reward-seeking actions, nucleus accumbens core (NAcC) D1R blockade had no effect on the speed of action initiation or impulsive actions. Instead, fine-grained analyses showed that this manipulation decreased the precision of animals' goal-directed actions, even though they usually still followed the appropriate response sequence. Strikingly, such "unfocused" responding could also be observed off-drug, particularly when only a small reward was on offer. These findings suggest that the balance of activity at NAcC D1Rs plays a key role in enabling the rapid activation of a focused, reward-seeking state to enable animals to efficiently and accurately achieve their goal.
Collapse
Affiliation(s)
- Laura L Grima
- Department of Experimental Psychology, University of Oxford, Oxford, UK.
- Janelia Research Campus, Howard Hughes Medical Institute, Ashburn, VA, USA.
| | - Marios C Panayi
- Department of Experimental Psychology, University of Oxford, Oxford, UK
- National Institute on Drug Abuse, Biomedical Research Center, 251 Bayview Boulevard, Suite 200, Baltimore, MD, 21224, USA
| | - Oliver Härmson
- Department of Experimental Psychology, University of Oxford, Oxford, UK
- Medical Research Council Brain Network Dynamics Unit, University of Oxford, Oxford, UK
| | - Emilie C J Syed
- Department of Experimental Psychology, University of Oxford, Oxford, UK
| | - Sanjay G Manohar
- Department of Experimental Psychology, University of Oxford, Oxford, UK
- Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK
| | - Masud Husain
- Department of Experimental Psychology, University of Oxford, Oxford, UK
- Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK
- Wellcome Centre for Integrative Neuroimaging, University of Oxford, Oxford, UK
| | - Mark E Walton
- Department of Experimental Psychology, University of Oxford, Oxford, UK.
- Wellcome Centre for Integrative Neuroimaging, University of Oxford, Oxford, UK.
| |
Collapse
|
3
|
Härmson O, Grima LL, Panayi MC, Husain M, Walton ME. 5-HT 2C receptor perturbation has bidirectional influence over instrumental vigour and restraint. Psychopharmacology (Berl) 2022; 239:123-140. [PMID: 34762147 PMCID: PMC8770415 DOI: 10.1007/s00213-021-05992-8] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/14/2021] [Accepted: 09/20/2021] [Indexed: 10/25/2022]
Abstract
The serotonin (5-HT) system, particularly the 5-HT2C receptor, has consistently been implicated in behavioural control. However, while some studies have focused on the role 5-HT2C receptors play in regulating motivation to work for reward, others have highlighted its importance in response restraint. To date, it is unclear how 5-HT transmission at this receptor regulates the balance of response invigoration and restraint in anticipation of future reward. In addition, it remains to be established how 5-HT2C receptors gate the influence of internal versus cue-driven processes over reward-guided actions. To elucidate these issues, we investigated the effects of administering the 5-HT2C receptor antagonist SB242084, both systemically and directly into the nucleus accumbens core (NAcC), in rats performing a Go/No-Go task for small or large rewards. The results were compared to the administration of d-amphetamine into the NAcC, which has previously been shown to promote behavioural activation. Systemic perturbation of 5-HT2C receptors-but crucially not intra-NAcC infusions-consistently boosted rats' performance and instrumental vigour on Go trials when they were required to act. Concomitantly, systemic administration also reduced their ability to withhold responding for rewards on No-Go trials, particularly late in the holding period. Notably, these effects were often apparent only when the reward on offer was small. By contrast, inducing a hyperdopaminergic state in the NAcC with d-amphetamine strongly impaired response restraint on No-Go trials both early and late in the holding period, as well as speeding action initiation. Together, these findings suggest that 5-HT2C receptor transmission, outside the NAcC, shapes the vigour of ongoing goal-directed action as well as the likelihood of responding as a function of expected reward.
Collapse
Affiliation(s)
- Oliver Härmson
- Department of Experimental Psychology, University of Oxford, Oxford, OX1 3SR, UK.
| | - Laura L Grima
- Department of Experimental Psychology, University of Oxford, Oxford, OX1 3SR, UK.
- Janelia Research Campus, Howard Hughes Medical Institute, Ashburn, VA, 20147, USA.
| | - Marios C Panayi
- Department of Experimental Psychology, University of Oxford, Oxford, OX1 3SR, UK
- National Institute On Drug Abuse, Biomedical Research Center, 251 Bayview Boulevard, Suite 200, Baltimore, MD, 21224, USA
| | - Masud Husain
- Department of Experimental Psychology, University of Oxford, Oxford, OX1 3SR, UK
- Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, OX1 9DU, UK
- Wellcome Centre for Integrative Neuroimaging, University of Oxford, Oxford, OX1 3SR, UK
| | - Mark E Walton
- Department of Experimental Psychology, University of Oxford, Oxford, OX1 3SR, UK.
- Wellcome Centre for Integrative Neuroimaging, University of Oxford, Oxford, OX1 3SR, UK.
| |
Collapse
|
4
|
Abstract
Assessment of oxidative stress is an important but technically challenging procedure in medical and biological research. The reactive oxygen metabolites (d-ROMs) test is a simple assay marketed for analyzing the total amount of hydroperoxides in serum via the Fenton's reaction. Earlier reports have raised a suspicion that a part of the signal detected in the assay comes from sources other than metabolites generated by oxidative stress. The aim of this study was to identify which serum components interfere with the d-ROMs signal. By application of sodium azide, ethylenediaminetetraacetic acid, sodium dodecylsulphate, varying temperature, and spiking endogenous substances we demonstrate that in the case of mammalian sera the assay determines ceruloplasmin (CP) activity with potential interferences from hydroperoxides, iron level, thiols, and albumin. In sera of avian species hydroperoxides contribute more to the test outcome, but the CP part is insensitive to inhibition by azide. In conclusion, this assay has deficiencies in terms of detecting realistic concentrations of hydroperoxides, is mostly measuring CP and is also interfered with other serum components, making it very difficult to interpret in most biological systems.
Collapse
Affiliation(s)
- K Kilk
- Department of Bio- and Translational Medicine, Centre of Excellence for Translational Medicine, University of Tartu , Tartu , Estonia
| | | | | | | | | |
Collapse
|